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Purpose: For many years, thoracic sympathectomy via open surgery was not used to treat Raynaud’s phenomenon because
of the invasiveness of this procedure and the poor long-term outcomes associated with it. However, with the introduction
of endoscopic surgery, thoracic sympathectomy (or sympathicotomy) has been performed by some surgeons as a less
invasive surgical option for patients with Raynaud’s phenomenon. The less invasive procedure has the possibility of
emphasizing merits of sympathectomy. The purpose of this study was to reevaluate the efficacy of sympathicotomy for
Raynaud’s phenomenon with endoscopic technique and its range of applicability.
Methods: Between December 1992 and August 2001, endoscopic thoracic sympathicotomy (ETS) was performed in 28
patients with Raynaud’s phenomenon (of a total of 502 patients with autonomic disorders who underwent ETS) at
National Kanazawa Hospital. We considered indications for surgical treatment of Raynaud’s phenomenon to include
severe chronic symptoms or nonhealing digital ulceration refractory to intensive medical therapy. All patients were mailed
a self-assessment questionnaire after surgery to determine the immediate and long-term results of the procedure. Data
from both initial and long-term follow-up examinations were obtained.
Results: Fifty-four ETS procedures were performed in 28 patients. No operative mortality was seen, and no occurrence of
major complications necessitated open surgery. Initial resolution or improvement of symptoms was achieved in 26 of 28
patients (92.9%). However, later in the postoperative period, symptoms recurred in 23 of 28 patients (82.1%), although
no recurrence of digital ulceration was seen throughout our observation. At the final follow-up examination (median
follow-up period, 62.5 months), 25 patients (89.3%) reported overall improvement of the frequency and severity of their
symptoms.
Conclusion: Despite the high rate of recurrence, ETS clearly produced a high rate of initial relief. ETS did indeed promote
healing of digital ulcers, and the procedure shows potential for reducing the severity of refractory symptoms. We consider
ETS to be the method of choice for treatment of severe or refractory Raynaud’s phenomenon, and especially for
Raynaud’s involving digital ulcer, because of its safety and efficacy. (J Vasc Surg 2002;36:57-61.)
Thoracic sympathectomy or sympathicotomy has been
used to treat a variety of upper limb disorders, including
hyperhidrosis, Raynaud’s phenomenon, and posttraumatic
pain syndrome. Use of cervicothoracic sympathectomy via
open surgery to treat Raynaud’s phenomenon was first
reported by Adson and Brown1 in 1929. However, in
recent years, this procedure has not been used to treat
Raynaud’s phenomenon because of the invasiveness of the
operation and the poor long-term outcomes associated
with it.2,3 Endoscopic thoracic sympathectomy, which was
first described by Kux4 in 1951, has been advocated as a less
invasive alternative procedure. A simplified version of this
technique, developed by Claes, Drott, and Gothberg5 and
known as endoscopic thoracic sympathicotomy (ETS), has
recently gained widespread popularity because of its advan-
tages over conventional surgical procedures and the earlier
version of endoscopic sympathectomy. By means of intro-
ducing less invasive endoscopic procedure, the merit of
sympathectomy may be increased. This report describes our
experiences with ETS in the treatment of Raynaud’s phe-
nomenon during the past decade, including immediate and
long-term results. We reevaluated the efficacy of sympa-
thectomy with the less invasive procedure for treatment of
Raynaud’s phenomenon and its range of applicability.
PATIENTS AND METHODS
Between December 1992 and August 2001, ETS was
performed in 502 consecutive patients at the Department
of Cardiovascular Surgery of National Kanazawa Hospital.
ETS has become an accepted and effective treatment for
hyperhidrosis, and application for angina pectoris has been
reported.6 Of these 502 patients, 28 patients had
Raynaud’s phenomenon and were selected as subjects for
this study (Table I). Of the 28 patients with Raynaud’s
phenomenon, 20 had primary Raynaud’s and eight had
secondary Raynaud’s involving connective tissue disorders.
Of the patients with secondary Raynaud’s phenomenon,
three had progressive systemic sclerosis, three had systemic
lupus erythematosus, one had cryoglobulinemia, and one
had calcinosis, Raynaud’s phenomenon, esophageal in-
volvement, sclerodactyly, and telangiectasia (or CREST)
syndrome. Eighteen of the 28 patients had positive results
for antinuclear antibody (ANA; primary:secondary, 10:8).
All had severe symptoms of cold intolerance that had not
responded to medical treatment with heated gloves or
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drugs. Seven patients had ulceration of their fingertips
(primary:secondary, 1:6; Table II). We considered indica-
tions for surgical treatment of Raynaud’s phenomenon to
include severe chronic symptoms that lasted more than 6
months or nonhealing digital ulceration refractory to inten-
sive medical therapy with administration of two or more
kinds of drugs (eg, prostaglandin, vasodilator, and antico-
agulant).
All patients were followed routinely every 3 months
after the operation as outpatients. Actually, 23 of 28 pa-
tients (82.1%) returned for follow-up examination. They
were mailed a simple self-assessment questionnaire for the
final follow-up examination (median follow-up period,
62.5 months after surgery) to determine both immediate
and long-term results of the procedure. In the question-
naire, patients were asked about the following: 1, period of
improvement (temporary or permanent); 2, negative post-
operative effects, including eyelid droop, change in pupil
size, abnormal sweating of the trunk, and duration of these
effects; 3, the patient’s overall opinion of the treatment in
retrospect; and 4, additional comments. Patients were di-
vided into three groups: those with active connective tissue
disease (CTD) and positive ANA, those without CTD and
with positive ANA, and those without CTD and with
negative ANA group. Data from both initial and long-term
follow-up examinations were obtained from these groups,
with investigation especially about healing digital ulcers.
Surgical procedure. The operation was performed
with general anesthesia with standard single-lumen endo-
tracheal intubation. The patient was in a semisitting posi-
tion on the operating table, with bilateral arms abducted to
90 degrees. After a 1-cm stab incision in the axillar space, a
Verres needle was inserted into the pleural space via the
incision (through the third intercostal space). The needle
was connected to a high-flow low-pressure carbon dioxide
supply, and gas was introduced (1.5 to 2 L). A 10-mm
urologic electroresectscope designed especially for sympa-
thicotomy, with a video camera attached, then was intro-
duced through the same incision. As the lung was de-
pressed with the carbon dioxide gas, an excellent surgical
view of the upper thoracic cavity was obtained. The sympa-
thetic chain could be seen as a white strand running down
over the heads of the ribs across to the costovertebral
junction. The sympathetic ganglia lying over the ribs were
electrocoagulated, leaving the nerves between the ribs un-
touched. Because the electrocautery was integral to the
instrument, only one incision had to be made on each side.
If the procedure was performed bilaterally, after exsuffla-
tion of the gas and closing of the wound without insertion
of a thoracic drain, the operation was repeated on the other
side. Ganglia thoracic vertebrae 2 to 4 were electrocauter-
ized. The mean surgical time for the bilateral procedure was
21 minutes. This procedure was performed as an overnight
surgery. Most of the patients resumed work within a few
days after the procedure.
RESULTS
From December 1992 to August 2001, 54 ETS proce-
dures were performed in 28 patients. The patients consisted
of 21 women and seven men, with a mean age of 46.4 years
(range, 26 to 73 years). Two patients underwent a unilat-
eral procedure, and the remaining patients underwent a
one-stage bilateral procedure with the same anesthetic. No
operative mortality was seen, and no occurrence of major
complications necessitated open surgery. None of the pa-
tients had minor perioperative complications develop, such
as Horner’s syndrome or pneumothorax necessitating chest
drainage. Reflex sweating (previously known as compensa-
tory sweating), a common side effect of ETS, was reported
by 24 patients who considered it a minor nuisance (Table
III). In one patient, Raynaud’s phenomenon coexisted
with thoracic outlet syndrome. This patient underwent
Table I. Conditions treated with ETS
Diseases
No. of
procedures/patients
Raynaud’s phenomenon 54/28
Hyperhidrosis 932/466
Buerger’s disease 6/3
Angina pectoris (effort & vasospastic) 6/3
Causalgia 4/2
Total 1002/502
Table II. Characteristics of patients with Raynaud’s
phenomenon who underwent ETS
No. of
patients
Raynaud’s phenomenon (mean age, 46.4 years) 28
Male:Female 7:21
Raynaud’s with connective tissue disease 8
Systemic lupus erythematosus 3
Progressive systemic sclerosis 3
Cryoglobulinemia 1
CREST syndrome 1
Positive for antinuclear antibody 18 (8)
Numbness and severe pain 28 (8)
Finger tip ulceration 7 (6)
CREST, Calcinosis, Raynaud’s phenomenon, esophageal involvement,
sclerodactyly, and telangiectasia.
Raynaud’s with connective tissue disease indicated by numbers in parenthe-
ses.
Table III. Perioperative complications for 54 ETSs
performed in 28 patients with Raynaud’s phenomenon
Complications
No. of
patients
Horner’s syndrome 0
Pneumothorax 0
Reflex sweating (compensatory sweating) 24
Neuralgia 0
Wound problem 0
Death 0
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thoracic vertebrae 2 to 4 ETS and reported that symptoms
initially improved but recurred 17 months after surgery.
However, after open surgery consisting of resection of the
first rib and stellate ganglionectomy, this patient’s condi-
tion showed improvement.
For evaluation of the efficacy of ETS, a self-assessment
questionnaire was mailed to all 28 patients, and all patients
returned a completed questionnaire. Initial resolution or
improvement of symptoms was achieved in 26 of the 28
patients (92.9%). However, within 16 months after sur-
gery, symptoms persisted or recurred in 23 of the 28
patients (82.1%). Seven of eight patients with active CTD
and positive ANA reported recurrence within 6 months,
and eight of 10 patients with no CTD and positive ANA
reported return of symptoms within 1 year. Six of 10
patients had recurrence in the no CTD and negative ANA
group. Patients with CTD or positive ANA tended to have
recurrence in the early period after surgery. However, no
clear association was found between postoperative course
and clinical factors, such as age, sex, smoking, or presence
of other serologic markers because our follow-up experi-
ence was small. Twenty of the 23 patients who had recur-
rence (87.0%) reported reduced frequency and severity of
symptoms at the final follow-up examination (median fol-
low-up period, 62.5 months after ETS; range, 12 to 104
months; Table IV).
Characteristics and operative results of the patients with
Raynaud’s phenomenon who had finger tip ulceration are
listed in Table V. Digital ulceration healed in all seven
patients within 1 month after surgery. Debridement was
performed to a patient who had ulceration with small
necrosis, and prostaglandin E1 ointment was effective for
healing digital ulcer. Quality of the skin covering the healed
ulcer was normal in almost all cases. No recurrence was seen
of digital ulceration and new ulcer formation during our
observation (follow-up period range, 12 to 91 months after
the operation).
DISCUSSION
Raynaud7 first described a clinical condition consisting
of episodic digital cyanosis and pallor induced by cold or
emotional stimuli in 1862. This phenomenon was believed
to be an abnormal vasospastic response mainly as a result of
an overactive sympathetic nervous system. On the basis of
this theory, cervicothoracic sympathectomy was performed
as a surgical treatment for Raynaud’s phenomenon.1,8-10
Although it was previously more widely used, this proce-
dure has rarely been performed for patients with Raynaud’s
phenomenon until now2,3 because of the invasiveness of
the procedure and the poor long-term outcome associated
with it. However, with the introduction of endoscopic
surgery, thoracic sympathectomy has been revived as a less
invasive surgical option for patients with Raynaud’s phe-
nomenon with no response to other therapies.10
With the decision of whether to perform ETS for
Raynaud’s phenomenon, the risks and complications of the
Table IV. Postoperative results of ETS in 28 patients with Raynaud’s phenomenon
With active CTD and
ANA() cases
(n  8)
With no collagen disease
and ANA() cases
(n  10)
With no collagen disease
and ANA (–) cases
(n  10)
Immediately results (cases)
Symptom-free 7/8 9/10 10/10
Better than preoperative values 0/8 0/10 1/10
Same as preoperative values 1/8 1/10 0/10
Deteriorated 0/8 0/10 0/10
Long term results (median, 62.5
months)
Symptom-free 0/8 1/10 4/10
Better than preoperative values 6/8 8/10 6/10
Same as preoperative values 1/8 1/10 0/10
Deteriorated 1/8 0/10 0/10
Recurrence
3 months 1/8
(same as preop.)
1/10
(same as preop.)
0/10
6 months 6/8 1/10 1/10
1 year 1/8 6/10 5/10
3 years 0/8 1/10 0/0
5 years 0/8 0/10 0/0
Total 8/8 9/10 6/10
Recurrent symptoms
Pallor or cyanosis 8/8 9/9 6/6
Pain 6/8 6/9 2/6
Ulceration 0/8 0/9 0/6
Symptom-free or reduced
frequency and symptom
severity (median, 62.5 months)
6/8 9/10;
symptom relief in
recurrent cases, 8/9
10/10;
symptom relief in
recurrent cases, 6/6
Median, 62.5 months; range, 12 to 104 months after surgery.
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procedure must be considered along with its limited ability
to alleviate symptoms. In our series, no major complica-
tions were seen and the results indicate that ETS is a less
invasive and safe procedure that can be performed without
mortality and with minimal morbidity. These results are
consistent with previously published findings.10,11 None of
the patients in this study had Horner’s syndrome. Although
Horner’s syndrome does not result in functional impair-
ment, it can have significant cosmetic effects. Our current
philosophy is not only to preserve the stellate ganglion but
also to use pure cutting current for electrocauterization of
the sympathetic trunk to avoid advanced degeneration of
the sympathetic nerve as the result of thermal injury from
electrocoagulation; the occurrence of Horner’s syndrome
in patients with ETS is associated with the amount of
energy involved in electrocoagulation.10 Also, because
sympathicotomy of ganglia from thoracic vertebrae 2 to 4
produces effects equal to those obtained with current open
surgery procedures12 and endoscopic sympathectomy,10
sympathicotomy is preferable to these other procedures
because it is the least invasive. Because fibers innervating
the upper extremities pass through the satellite ganglion,
resection of all or a portion of the satellite ganglion was
previously considered necessary for complete sympathec-
tomy. However, these results indicate that it is not neces-
sary for sympathicotomy to include stellate and T1 ganglia.
Other researchers have also advocated preservation of the
satellite ganglion.2,5
In this study, most patients with Raynaud’s phenome-
non who underwent ETS had recurrent symptoms. These
findings agree with previous reports of a high recurrence
rate.2,3 The mechanism of recurrence of symptoms is un-
known, but recurrence may be caused by surgical error (eg,
incomplete sympathectomy),13 sympathetic renervation,14
hypersensitivity of digital vessels to circulating cat-
echolamines,15,16 or progressive vasculitis (in patients with
collagen disease). In a survey of 470 patients who under-
went ETS for hand sweating, we found that all patients had
warm skin temperature of the hands for approximately 6
months. The skin temperature normalized after this period,
and no recurrence of hyperhidrosis was found. These find-
ings are similar to those reported by Claes, Drott and
Gothberg,17 and they indicate that rerouting of the path-
way responsible for regulation of skin circulation may oc-
cur.
Reported results of use of ETS for treatment of
Raynaud’s phenomenon vary greatly. Adams et al18 re-
ported immediate improvement of symptoms in nine of 10
ETS procedures performed to treat Raynaud’s phenome-
non, but the degree of improvement decreased with time.
Our success rate for treatment of Raynaud’s phenomenon
also was impressive immediately after ETS (92.9%) but fell
to 17.9% at the final follow-up examination (median fol-
low-up period, 62.5 months after ETS). Symptoms re-
curred in all patients with collagen disease. Furthermore, in
our series, patients with active collagen disease or positive
ANA tended to have recurrence in the early period after
surgery. To find the predictors, we tried various analyses.
However, the number of our series was so small that we
could not find any clear association.
Surveys of the available data, which indicate inconsis-
tent results after ETS, has led some surgeons to conclude
that thoracic sympathicotomy is not indicated for patients
with Raynaud’s phenomenon. Given these limitations, ETS
appears to be only warranted for treatment of patients
seeking relief from disabling symptoms that are refractory
to intensive medical therapy. We previously restricted ETS
to treatment of patients with no response to any other
therapies. However, the results of this self-assessment ques-
tionnaire have caused us to reassess this position. Despite
recurrence of symptoms, 89.3% of the patients (25 of 28) in
this series reported reduced frequency and severity of symp-
toms. Also, even in the patients with Raynaud’s phenome-
non and collagen disease, no recurrence of digital ulcer-
ation was seen and recurrent symptoms were less severe
than preoperative symptoms.
Regarding digital ulcer of the Raynaud’s, digital ulcer-
ation healed in all seven patients within 1 month after
surgery. And no recurrence or new ulcer formation was
seen throughout our observation (range, 12 to 91
months). This fact indicates that ETS is effective for
Raynaud’s phenomenon with digital ulceration. Why ETS
produces healing digital ulcer despite the high recurrent
rate of Raynaud’s phenomenon is unclear. However, we
think Raynaud’s phenomenon with digital ulcer has both
functional and organic (microvessel obstruction because of
Table V. Patients of Raynaud’s phenomenon with finger tip ulceration
Case
Age/sex,
CTD/ANA
Size (mm)/
no./necrosis
Healing/
duration
(wk)
Quality of
skin
Recurrent/
new ulcer/follow-up
(mo)
Aggressive skin
care
Debridement/
amputation
1 48/M, SLE/() 6/1/() ()/4 Normal ()/()/91 () ()/()
2 53/F, PSS/() 7/1/() ()/4 Normal ()/()/82 () ()/()
3 62/F, CREST/() 8/1/() ()/4 Normal ()/()/67 () ()/()
4 45/F, ()/() 5/1/() ()/4 Normal ()/()/48 () ()/()
5 37/F, PSS/() 11/1/() ()/4 Dimple () ()/()/46 PGE1 ointment ()/()
6 44/F, CG/() 6 & 6/2/() ()/2 Dimple () ()/()/23 PGE1 ointment ()/()
7 57/F, SLE/() 10/1/() ()/3 Normal ()/()/12 PGE1 ointment ()/()
M, Male; F, female; SLE, systemic lupus erythematosus; PSS, progressive systemic sclerosis; CG, cryoglobulinemia; CREST, calcinosis, Raynaud’s phenome-
non, esophageal involvement, sclerodactyly, and telangiectasia syndrome; PG, prostaglandin.
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vasculitis) problems, and ETS improves basic microvascular
circulation of the finger continuously and promotes long-
term healing of ulcer and its preventing effect for abnormal
vasospastic response lasts for a few months.
With these results and the low risk of this operation, the
efficacy of ETS for patients with Raynaud’s phenomenon
should be reevaluated. Although we have found that most
patients have recurrent symptoms, ETS clearly produces
significant initial relief. ETS indeed promoted healing of
digital ulcers, prevented new ulcer formation, and showed
potential for reducing the severity of refractory symptoms.
After consultation regarding the limited benefits that can
be expected from sympathectomy, patients with Raynaud’s
phenomenon may elect to undergo the operation and they
should not be denied this low-risk procedure. A patient’s
understanding and satisfaction can be enhanced with pre-
operative and postoperative counseling.
CONCLUSION
Despite the high rate of recurrence after ETS, the
frequency and severity of symptoms were reduced. Of the
patients who underwent ETS for Raynaud’s phenomenon
in this study, 89.3% reported that the procedure produced
beneficial long-term results. And ETS indeed promoted
healing of digital ulceration. We consider ETS to be the
method of choice for Raynaud’s phenomenon, especially
for Raynaud’s involving digital ulcer, because the proce-
dure is easy, safe, and less invasive and produces satisfactory
results.
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